insights_auto
Why is GALT down 2.62%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$2.97
arrow_downward
-2.62%(-0.080) 1D
Nov 16, 1:40:32 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.11
High
$3.21
Low
$2.93
Mkt. cap
299.52M
Avg. vol.
203.02K
Volume
141.68K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.11
High
$3.21
Low
$2.93
Mkt. cap
299.52M
Avg. vol.
203.02K
Volume
141.68K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
AlphaStreet
·
3 hours ago
Galectin Therapeutics Releases Q3 2026 Financial Results
marketscreener.com
·
4 hours ago
Galectin Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
scanx.trade
·
5 hours ago
Galectin Therapeutics Q3 Results: Loss narrows 69% YoY to $0.04 per share
The Manila Times
·
5 hours ago
Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com